Publicaciones en colaboración con investigadores/as de University Hospital of Zurich (4)

2019

  1. Inhibitor of differentiation-1 sustains mutant KRAS-driven progression, maintenance, and metastasis of lung adenocarcinoma via regulation of a FOSL1 network

    Cancer Research, Vol. 79, Núm. 3, pp. 625-638

2017

  1. The inhibitor of differentiation-1 (Id1) enables lung cancer liver colonization through activation of an EMT program in tumor cells and establishment of the pre-metastatic niche

    Cancer Letters, Vol. 402, pp. 43-51

2010

  1. Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 37, Núm. 5, pp. 1049-1062

2008

  1. The specific case of radiopharmaceuticals and GMP - Activities of the Radiopharmacy Committee

    European Journal of Nuclear Medicine and Molecular Imaging